Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:16759302rdf:typepubmed:Citationlld:pubmed
pubmed-article:16759302lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:16759302lifeskim:mentionsumls-concept:C0332307lld:lifeskim
pubmed-article:16759302lifeskim:mentionsumls-concept:C0011860lld:lifeskim
pubmed-article:16759302lifeskim:mentionsumls-concept:C0062534lld:lifeskim
pubmed-article:16759302lifeskim:mentionsumls-concept:C0577631lld:lifeskim
pubmed-article:16759302lifeskim:mentionsumls-concept:C1519104lld:lifeskim
pubmed-article:16759302lifeskim:mentionsumls-concept:C0175630lld:lifeskim
pubmed-article:16759302lifeskim:mentionsumls-concept:C2826293lld:lifeskim
pubmed-article:16759302pubmed:issue6lld:pubmed
pubmed-article:16759302pubmed:dateCreated2006-6-8lld:pubmed
pubmed-article:16759302pubmed:abstractTextRecent studies have provided increasing evidence that hepatocyte growth factor (HGF) has a pathophysiological role in the development of diabetic complications. We set out to determine the relationship between serum HGF and risk factors for macroangiopathy including carotid atherosclerosis. Carotid atherosclerosis is an established and important risk factor for both cerebral and coronary artery diseases.lld:pubmed
pubmed-article:16759302pubmed:languageenglld:pubmed
pubmed-article:16759302pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16759302pubmed:citationSubsetIMlld:pubmed
pubmed-article:16759302pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16759302pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16759302pubmed:statusMEDLINElld:pubmed
pubmed-article:16759302pubmed:monthJunlld:pubmed
pubmed-article:16759302pubmed:issn0742-3071lld:pubmed
pubmed-article:16759302pubmed:authorpubmed-author:IshikawaTTlld:pubmed
pubmed-article:16759302pubmed:authorpubmed-author:HasegawaYYlld:pubmed
pubmed-article:16759302pubmed:authorpubmed-author:KohriKKlld:pubmed
pubmed-article:16759302pubmed:authorpubmed-author:NambaMMlld:pubmed
pubmed-article:16759302pubmed:authorpubmed-author:NütaniKKlld:pubmed
pubmed-article:16759302pubmed:authorpubmed-author:HamaguchiTTlld:pubmed
pubmed-article:16759302pubmed:authorpubmed-author:KonyaHHlld:pubmed
pubmed-article:16759302pubmed:authorpubmed-author:KakishitaEElld:pubmed
pubmed-article:16759302pubmed:authorpubmed-author:SuehiroAAlld:pubmed
pubmed-article:16759302pubmed:authorpubmed-author:KatsunoTTlld:pubmed
pubmed-article:16759302pubmed:authorpubmed-author:UmeharaAAlld:pubmed
pubmed-article:16759302pubmed:issnTypePrintlld:pubmed
pubmed-article:16759302pubmed:volume23lld:pubmed
pubmed-article:16759302pubmed:ownerNLMlld:pubmed
pubmed-article:16759302pubmed:authorsCompleteYlld:pubmed
pubmed-article:16759302pubmed:pagination617-22lld:pubmed
pubmed-article:16759302pubmed:meshHeadingpubmed-meshheading:16759302...lld:pubmed
pubmed-article:16759302pubmed:meshHeadingpubmed-meshheading:16759302...lld:pubmed
pubmed-article:16759302pubmed:meshHeadingpubmed-meshheading:16759302...lld:pubmed
pubmed-article:16759302pubmed:meshHeadingpubmed-meshheading:16759302...lld:pubmed
pubmed-article:16759302pubmed:meshHeadingpubmed-meshheading:16759302...lld:pubmed
pubmed-article:16759302pubmed:meshHeadingpubmed-meshheading:16759302...lld:pubmed
pubmed-article:16759302pubmed:meshHeadingpubmed-meshheading:16759302...lld:pubmed
pubmed-article:16759302pubmed:meshHeadingpubmed-meshheading:16759302...lld:pubmed
pubmed-article:16759302pubmed:meshHeadingpubmed-meshheading:16759302...lld:pubmed
pubmed-article:16759302pubmed:meshHeadingpubmed-meshheading:16759302...lld:pubmed
pubmed-article:16759302pubmed:meshHeadingpubmed-meshheading:16759302...lld:pubmed
pubmed-article:16759302pubmed:meshHeadingpubmed-meshheading:16759302...lld:pubmed
pubmed-article:16759302pubmed:meshHeadingpubmed-meshheading:16759302...lld:pubmed
pubmed-article:16759302pubmed:meshHeadingpubmed-meshheading:16759302...lld:pubmed
pubmed-article:16759302pubmed:meshHeadingpubmed-meshheading:16759302...lld:pubmed
pubmed-article:16759302pubmed:meshHeadingpubmed-meshheading:16759302...lld:pubmed
pubmed-article:16759302pubmed:meshHeadingpubmed-meshheading:16759302...lld:pubmed
pubmed-article:16759302pubmed:meshHeadingpubmed-meshheading:16759302...lld:pubmed
pubmed-article:16759302pubmed:meshHeadingpubmed-meshheading:16759302...lld:pubmed
pubmed-article:16759302pubmed:year2006lld:pubmed
pubmed-article:16759302pubmed:articleTitleClinical significance of circulating hepatocyte growth factor, a new risk marker of carotid atherosclerosis in patients with Type 2 diabetes.lld:pubmed
pubmed-article:16759302pubmed:affiliationThe Division of Diabetes and Metabolism, Internal Medicine, Hyogo College of Medicine, Nishinomiya, Hyogo, Japan.lld:pubmed
pubmed-article:16759302pubmed:publicationTypeJournal Articlelld:pubmed
entrez-gene:24446entrezgene:pubmedpubmed-article:16759302lld:entrezgene